Is There a Solution for Absolute Metabolic Collapse?

It doesn't matter how many calories you consume – the deeper we delve into biology, the more significant this statement becomes. Your metabolism is ultimately determined by how efficiently your mitochondria (the energy centers of your cells) synthesize energy (ATP) from the food you take in. The flow of electrons in the mitochondria, oxygen consumption and utilization – everything depends on available fuel sources and efficient transport.

Metabolic Collapse – What Is It?

Metabolic collapse is a state in which mitochondrial energy production (ATP) becomes critically impaired due to a biochemical blockade – such as coenzyme A sequestration – leading to a systemic energy failure of the cells, even with an adequate calorie supply.

Coenzyme A (CoA) sequestration (entrapment) is the primary cause of metabolic decompensation in numerous pathologies, metabolic disorders, nutritional deficiencies, and genetic disorders. Coenzyme A is the heart of the electron transport chain – it is crucial for efficient energy production. The inability to produce energy or process metabolic waste triggers a "systemic energy failure" along with cellular stress and toxicity.

"Without energy, life would be extinguished instantly, and the cellular structure would collapse." – Albert Szent-Györgyi, Nobel Laureate

Metabolic Consequences

CoA sequestration: unesterified CoA (CoASH) is trapped within the cell through the formation of stable CoA-thioester complexes.

The accumulation of metabolites causes coupled inhibition of key enzymes, such as pantothenate kinase (PanK), effectively suppressing the cell's ability to synthesize new CoA. As a result, the cell enters a vicious cycle: not only does it lack free CoA for energy production, but it also loses the capacity to generate it anew.

This process depletes free, active CoA reserves, critically impairing key metabolic pathways such as the Krebs cycle, fatty acid β-oxidation, carbohydrate metabolism, and cellular energy production.

What can be the cause? For example, CoA sequestration triggered by BCAAs, high-fat diets, fasting, and diabetes.

The Role of Glycine in Metabolism

The question arises: how can we free this "trapped" CoA and break the vicious cycle of metabolic insufficiency? The answer may lie in a simple amino acid – glycine.

Glycine may offer a solution:

• Through a detoxification process called glycine conjugation, catalyzed by the enzyme GLYAT, glycine binds to these harmful acyl-CoA intermediates, enabling their safe removal from the body in urine, effectively freeing (recycling) the trapped CoA.
• Restoring ATP: the newly liberated CoA−SH can immediately re-enter β-oxidation and the Krebs cycle to resume normal ATP (energy) production.

Restoring Brain Energy

The effects of this biochemical "reset" are particularly felt in the organ with the highest energy demand – the brain. Restoring mitochondrial function is fundamentally important here, not only for energy but also for the structural integrity of neurons.

An abundance of free CoA restores mitochondrial function, allowing the brain to produce ATP, synthesize myelin, and remove toxins. Moreover, by safely buffering and eliminating toxic acyl-CoA intermediates, this process indirectly prevents neuronal cell damage, oxidative stress, and inflammation associated with organic acids.

Furthermore, glycine's role in the brain extends far beyond energy metabolism, creating a bridge between cellular biochemistry and neurophysiology. Glycine acts as a key inhibitory neurotransmitter in the spinal cord and brainstem. It modulates motor reflexes and plays a role in regulating responses to sensory stimuli, particularly in conditions of heightened anxiety, stress, or PTSD.

Potential Clinical Applications

It is this dual mechanism of action – metabolic and neurotransmissive – that makes glycine a promising therapeutic molecule. In conditions such as hyperekplexia, where the startle reflex is exaggerated, glycine's stabilizing influence on neurotransmission holds therapeutic significance and suggests its clinical potential in corrective therapies.

How to use glycine?

Considering the above potential, the question of safe and effective supplementation arises. In general, glycine supplements are well-tolerated, and at typical supplemental doses of 3–5 g/day, no serious adverse effects have been observed.

Even at very high doses (up to 90 g/day for several weeks!), glycine has been used in schizophrenia research without serious side effects, although gastrointestinal symptoms become more common.

In addition to supplements, it is worth remembering natural sources. Collagen is also a good source of glycine. You can read about how to effectively use collagen here.

Combining Glycine with NAD+

To maximize the metabolic benefits, it is worth considering combining glycine with another key coenzyme – NAD+.

The human body must maintain a strict glycine balance. Excess glycine is metabolized by the glycine cleavage system (GCS), which requires NAD+ and generates NADH. The resulting NADH can be used for energy (ATP) production, although it can sometimes alter metabolic pathways.

Combining with NAD+ not only supports the conversion of metabolites to glycine but also increases overall metabolic efficiency. In other words, while glycine frees up the blocked CoA, NAD+ helps with the utilization of excess glycine and sustains the energy cycle, creating a synergistic duo that supports the mitochondria.

Summary

From the mitochondrial level to the functioning of the nervous system, glycine presents a multifaceted approach to resolving the metabolic blockade caused by CoA sequestration, offering significant benefits for the central nervous system. Its inhibitory influence on motor reflexes and its potential to alleviate anxiety reinforce its therapeutic properties.

References:

Glycine N‐Acyltransferase Deficiency due to a Homozygous Nonsense Variant in the GLYAT: A Novel Inborn Error of Metabolism PMC12307128

Coenzyme a Biochemistry: From Neurodevelopment to Neurodegeneration PMC8392065

Coenzyme A in Brain Biology and Neurodegeneration PMC12839256

The glycine N-acyltransferases, GLYAT and GLYATL1, contribute to the detoxification of isovaleryl-CoA - an in-silico and in vitro validation PMC9932296

Pantothenate kinase activation relieves coenzyme A sequestration and improves mitochondrial function in mice with propionic acidemia DOI: 10.1126/scitranslmed.abf596

Functional Characterisation of Three Glycine N-Acyltransferase Variants and the Effect on Glycine Conjugation to Benzoyl–CoA PMC8003330

The Glycinergic System in Human Startle Disease: A Genetic Screening Approach PMC2854534

Glycine neurotransmitter transporters: an update PMID: 11396606

Glycinergic signaling in the human nervous system: An overview of therapeutic drug targets and clinical effects PMC6007534

Sources and implications of NADH/NAD+ redox imbalance in diabetes and its complications PMC4869616

This article is for informational purposes only and is not intended as medical advice. It should not replace professional medical assessment, diagnosis, or treatment. If you have health concerns, please consult a qualified healthcare professional.